Nature Communications (Mar 2023)

Histone demethylase KDM2A is a selective vulnerability of cancers relying on alternative telomere maintenance

  • Fei Li,
  • Yizhe Wang,
  • Inah Hwang,
  • Ja-Young Jang,
  • Libo Xu,
  • Zhong Deng,
  • Eun Young Yu,
  • Yiming Cai,
  • Caizhi Wu,
  • Zhenbo Han,
  • Yu-Han Huang,
  • Xiangao Huang,
  • Ling Zhang,
  • Jun Yao,
  • Neal F. Lue,
  • Paul M. Lieberman,
  • Haoqiang Ying,
  • Jihye Paik,
  • Hongwu Zheng

DOI
https://doi.org/10.1038/s41467-023-37480-2
Journal volume & issue
Vol. 14, no. 1
pp. 1 – 16

Abstract

Read online

Alternative lengthening of telomeres (ALT) provides cancer cells a mechanism to sustain replicative immortality. Here, the authors identify KDM2A as a molecular vulnerability in ALT-dependent cancer cells and demonstrate its role in the resolution of ALT-specific telomere clusters via recruitment of SENP6.